Atlas Trials

Comparison of Captisol-Enabled™ Iohexol and Omnipaque™ in Patients With Impaired Renal Function Undergoing Coronary Angiography

Clinical trial NCT04627831 · WITHDRAWN

Trial details

NCT number
NCT04627831
Sponsor
Ligand Pharmaceuticals
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Contrast-induced Nephropathy
Start date
2022-01-01
Primary completion
2023-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.